GAITHERSBURG, Md. (AP) _ Altimmune Inc. (ALT) on Thursday reported a third-quarter loss of $29.9 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $2.05. Losses, adjusted for asset impairment costs, came to 34 cents per share.
The developer of immune therapy treatments posted revenue of $4.6 million in the period.
In the final minutes of trading on Thursday, the company's shares hit $2.26. A year ago, they were trading at $29.